![Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? | Immunology Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? | Immunology](https://www.frontiersin.org/files/Articles/754413/fimmu-12-754413-HTML-r1/image_m/fimmu-12-754413-g001.jpg)
Frontiers | Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? | Immunology
![PDF) Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus PDF) Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus](https://i1.rgstatic.net/publication/321682770_Developing_a_Standard_Set_of_Patient-Centred_Outcomes_for_Inflammatory_Bowel_Disease_-_an_International_Cross-disciplinary_Consensus/links/5e7652a04585157b9a511a12/largepreview.png)
PDF) Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease - an International, Cross-disciplinary Consensus
![Frontiers | An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians' Perspective | Pharmacology Frontiers | An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians' Perspective | Pharmacology](https://www.frontiersin.org/files/Articles/655054/fphar-12-655054-HTML-r1/image_m/fphar-12-655054-g001.jpg)